0000899243-20-033739.txt : 20201214 0000899243-20-033739.hdr.sgml : 20201214 20201214162059 ACCESSION NUMBER: 0000899243-20-033739 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201210 FILED AS OF DATE: 20201214 DATE AS OF CHANGE: 20201214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: IVERS-READ GILLIAN C CENTRAL INDEX KEY: 0001268304 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35347 FILM NUMBER: 201386399 MAIL ADDRESS: STREET 1: C/O PHARMION CORPORATION STREET 2: 2525 28TH STREET CITY: BOULDER STATE: CO ZIP: 80301 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Clovis Oncology, Inc. CENTRAL INDEX KEY: 0001466301 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 900475355 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5500 FLATIRON PARKWAY STREET 2: SUITE 100 CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: (303) 625-5000 MAIL ADDRESS: STREET 1: 5500 FLATIRON PARKWAY STREET 2: SUITE 100 CITY: BOULDER STATE: CO ZIP: 80301 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-12-10 0 0001466301 Clovis Oncology, Inc. CLVS 0001268304 IVERS-READ GILLIAN C C/O CLOVIS ONCOLOGY, INC. 5500 FLATIRON PARKWAY, SUITE 100 BOULDER CO 80301 0 1 0 0 See Remarks Common Stock 2020-12-10 4 M 0 68965 3.28 A 284487 D Common Stock 2020-12-10 4 F 0 52447 4.81 D 232040 D Employee Stock Option (right to buy) 3.28 2020-12-10 4 M 0 68965 0.00 D 2021-03-08 Common Stock 68965 0 D The option vested as to 25% of the shares on March 8, 2012, and the remainder vested in substantially equal installments over the 36 months immediately following such date. Executive Vice President of Technical Operations and Chief Regulatory Officer /s/ Gillian C. Ivers-Read 2020-12-13